Michael Barbella, Managing Editor11.05.22
New technologies were the major traffic drivers on ODT's website this past week.
MicroPort Ortho, Smith+Nephew plc, and Red Point Medical 3D each debuted new products while CurvaFix won FDA clearance for a new implant.
Topping page views was the rollout of MicroPort's HIPTURN (Tension Under ReductioN) device, which gives surgeons the tool to trial different offset and neck options during hip replacement without removing any constructs. The instrument removes the need for multiple trials to save OR time and save costs. It integrates into MicroPort’s Hip product line including the Profemur hip stems, Dynasty and Prime acetabular cups, and using the SuperPath and AnteriorPath surgical techniques.
Next in line with story clicks was Smith+Nephew, which introduced its new JOURNEY II ROX total knee—a reverse hybrid construct for total knee arthroplasty. The new knee has an advanced bearing material and anatomic design, combined with the efficiency and potential long-term tibia fixation of a cementless knee. The JOURNEY II ROX is compatible with S+N’s CORI surgical system, allowing surgeons access to next-generation robotic-assisted technology.
Also attracting cybervisitors was Red Point Medical 3D's introduction of the RPM-3D Intelliguide System, an advanced patient-specific deformity correction system. Using the power of AI-enabled surgical planning software, customized surgical techniques, and custom 3-D printed cutting guides, complex deformity correction is now more streamlined and accurate than before. Advantages of using RPM Intelliguide cut guides versus traditional standard instrumentation (SI) include improved predictability and reproducibility; hardware-agnostic RPM custom cutting guides; reduced costs, X-ray exposure, and surgical times; hardware planning; reduced intraoperative stresses associated with complex deformity correction; and improved patient and surgeon satisfaction.
CurvaFix amassed significant page views too, with the FDA clearance of its smaller-diameter (7.5 mm) CurvaFix IM (intramedullary) implant for fixation of pelvic fractures. Clinical case reports have shown the CurvaFix IM implant achieves strong, stable fixation that follows and fills natural curvature of anatomy, which can reduce pain, allow for earlier mobility, and boost recovery. The system aims to simplify pelvic fracture fixation surgery with a fast, easy, repeatable, minimally invasive procedure.
MicroPort Ortho, Smith+Nephew plc, and Red Point Medical 3D each debuted new products while CurvaFix won FDA clearance for a new implant.
Topping page views was the rollout of MicroPort's HIPTURN (Tension Under ReductioN) device, which gives surgeons the tool to trial different offset and neck options during hip replacement without removing any constructs. The instrument removes the need for multiple trials to save OR time and save costs. It integrates into MicroPort’s Hip product line including the Profemur hip stems, Dynasty and Prime acetabular cups, and using the SuperPath and AnteriorPath surgical techniques.
Next in line with story clicks was Smith+Nephew, which introduced its new JOURNEY II ROX total knee—a reverse hybrid construct for total knee arthroplasty. The new knee has an advanced bearing material and anatomic design, combined with the efficiency and potential long-term tibia fixation of a cementless knee. The JOURNEY II ROX is compatible with S+N’s CORI surgical system, allowing surgeons access to next-generation robotic-assisted technology.
Also attracting cybervisitors was Red Point Medical 3D's introduction of the RPM-3D Intelliguide System, an advanced patient-specific deformity correction system. Using the power of AI-enabled surgical planning software, customized surgical techniques, and custom 3-D printed cutting guides, complex deformity correction is now more streamlined and accurate than before. Advantages of using RPM Intelliguide cut guides versus traditional standard instrumentation (SI) include improved predictability and reproducibility; hardware-agnostic RPM custom cutting guides; reduced costs, X-ray exposure, and surgical times; hardware planning; reduced intraoperative stresses associated with complex deformity correction; and improved patient and surgeon satisfaction.
CurvaFix amassed significant page views too, with the FDA clearance of its smaller-diameter (7.5 mm) CurvaFix IM (intramedullary) implant for fixation of pelvic fractures. Clinical case reports have shown the CurvaFix IM implant achieves strong, stable fixation that follows and fills natural curvature of anatomy, which can reduce pain, allow for earlier mobility, and boost recovery. The system aims to simplify pelvic fracture fixation surgery with a fast, easy, repeatable, minimally invasive procedure.